DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2023
    • Call for Papers
    • Sponsor and Exhibit
    • New Researcher Network
    • Conference Logistics
    • Media Partners
  • Archive
    • Conference Papers Archive
    • DDL2022
      • APS Workshop
      • Conference Papers
      • DDL2022 Programme
      • DDL2022 Speakers
      • DDL2022 Sponsors
      • DDL2022 Photo Album
    • DDL2021
      • Conference Papers
      • DDL2021 Programme
      • DDL2021 Speakers
      • DDL2021 Sponsors
    • DDL2020
      • Conference Papers
      • Speakers and Lecture Recordings
      • Sponsors
    • DDL2019
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2019 Photo Album
    • DDL2018
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2018 Photo Album
    • DDL2017
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2017 Photo Album
    • DDL2016
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2015
      • Conference Papers
    • Previous Years
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • Scientific Advisors
  • Associated Events
    • EPSRC CDT in Aerosol Science Annual Conference 2023
    • ERS International Congress 2023
    • ISAM Congress 2023
    • RDD Europe 2023
  • Contact
  • The Aerosol Society logo
Mohammad Momin :

Mohammad Momin

Virginia Commonwealth University

Paper: Physicochemical and Aerosolization Performance Stability of an Excipient Enhanced Growth (EEG) Synthetic Lung Surfactant Powder Formulation

I am Mohammad Momin a Postdoctoral Fellow in the Department of Pharmaceutics at the School of Pharmacy in Virginia Commonwealth University, USA. I received my Ph.D. in Pharmacy from University of Otago in New Zealand in 2018 and my Bachelor’s in Pharmacy and Master’s in Pharmaceutical Science from Jahangirnagar University in Dhaka, Bangladesh. Before starting my PhD I worked more than 5 years in Pharmaceutical Industries of Bangladesh where I got interested in aerosol research. Immediately after my PhD, I started to work as a Postdoctoral Fellow under Professor Mike Hindle at Virginia Commonwealth University. My current research focuses on the development of high efficiency surfactant dry powder inhaler for both neonates and adults to treat both neonatal (NRDS) and adult respiratory distress syndrome (ARDS) using our excipient enhanced growth (EEG) formulation technology. I published more than 30 peer-reviewed journal articles, over 10 peer-reviewed conference papers, one submitted patent, and over 20 conference abstracts. I have also been serving as a co-guest editor of a special issue of Respiratory drug delivery section in Frontiers in Drug Delivery journal. I am the reviewer board member of MDPI journals and a member of American Association of Pharmaceutical Scientists (AAPS). I have also been reviewing articles for most of the journals in our field including International Journal of Pharmaceutics (IJP), European Journal of Pharmaceutical Sciences (EJPS), Journal of Pharmaceutical Sciences (JPS) and AAPS PhramSciTech etc. My PhD thesis has been awarded as the “Exceptional Doctoral Thesis” in division of health sciences by University of Otago, New Zealand. I have also been awarded with several presentation awards including Best student presentation award by New Zealand-Australian Controlled Release Society (NZAUS-CRS) in 2017, best student presentation winner in Otago Global Health Institute (OGHI) Conference in 2016 and first place in Three Minute Thesis (3MT) competition 2017 in the School of Pharmacy at University of Otago, New Zealand.

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2023 Drug Delivery to the Lungs Website design: definingdesign.co.uk